Skip to main content

Table 4 Correlations between optical coherence tomography measurements and various metabolic markers

From: Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography

Variables Coefficients SE t p value
For variability of NIT
 MAGE 0.267 0.072 3.668 0.0006
 Age −0.071 0.278 −0.258 0.80
 HbA1c 0.867 4.257 0.203 0.83
 1,5 AG −0.403 0.382 −1.054 0.29
 Mean BG 0.210 0.131 1.596 0.11
 Time in hypoglycemia 1.979 0.894 2.214 0.03
 DM duration 0.738 0.473 1.560 0.12
 HOMA R −2.247 1.183 −1.899 0.06
 Male −12.36 8.000 −1.545 0.12
 LDL cholesterol 0.002 0.152 0.018 0.98
 HDL cholesterol 0.243 0.251 0.967 0.33
 TG −0.047 0.052 −0.902 0.37
 CRP −8.176 13.66 −0.598 0.55
For percentage of uncovered struts
 MAGE 0.016 0.002 6.092 <0.0001
 Age 0.020 0.011 1.740 0.11
 HbA1c 0.183 0.180 1.016 0.31
 1,5 AG −0.028 0.016 −1.760 0.084
 Mean BG 0.006 0.005 1.135 0.26
 Time in hypoglycemia 0.072 0.039 1.835 0.072
 DM duration −0.018 0.020 −0.889 0.37
 HOMA R −0.067 0.051 −1.306 0.19
 Male 0.710 0.334 2.122 0.039
 LDL cholesterol 0.002 0.006 0.376 0.70
 HDL cholesterol 0.009 0.010 0.850 0.39
 TG −0.001 0.002 −0.810 0.42
 CRP 0.794 0.576 1.379 0.17
  1. BG blood glucose, CRP C-reactive protein, DM diabetes mellitus, HbA1c glycated hemoglobin, HDL cholesterol: high-density lipoprotein cholesterol, HOMA R homeostasis model assessment ratio, LDL cholesterol low-density lipoprotein cholesterol, MAGE mean amplitude of glycemic excursion, TG triglycerides